Strain Name: |
B6.Cg-Tg(Eno2tTA)5030Nes/J |
|---|---|
Stock Number: |
003763 |
Availability: | Repository-Cryopreserved |
General Terms and Conditions |
| Genes & Alleles | Eno2; tTA; Tg(Eno2tTA)5030Nes; |
Type JAX® GEMM® Strain - Congenic Additional information on JAX® GEMM® Strains. Type JAX® GEMM® Strain - Mutant Strain Type JAX® GEMM® Strain - Transgenic Species laboratory mouse Background Strain C57BL/6 Donor Strain mixed stock Donating Investigator Eric Nestler, UT Southwestern Medical Center Generation N7+5pN1 Appearance
black
Related Genotype: a/aStrain Description
These transgenic mice express the tetracycline-controlled activator protein (tTA) under the control of a rat neuron-specific enolase (Eno2) promoter. Although the Eno2 promoter has been shown to direct high levels of expression in brain tissue in general, this strain selectively expresses tTA at high levels in the striatum and to a lesser extent in the cerebral cortex and hippocampus. When these transgenic mice are mated to a second transgenic strain carrying a gene of interest under the regulation of a tetracycline-responsive promoter element (TRE; tetO), expression of the target gene in the bitransgenic offspring may be induced in the tTA-expressing tissues by the withdrawl of the tetracycline analog, doxycycline (dox). For example, when these transgenic mice are bred with Stock No. 003762, a transgenic strain that expresses a Fosb variant under the direction of a TRE, the resulting bitransgenic offspring can be induced to express high levels of the Fosb variant in the striatum by withdrawing dox.Strain Development
A transgenic construct containing a modified tTa cDNA under the control of an Eno2 (Enolase 2, gamma, neuronal) promoter, an SV40 intron and a poly A signal sequence, was injected into the pronuclei of oocytes from B6;SJL mice. Founder mice (line A in the primary reference) were mated to ICR mice and then backcrossed to C57BL/6J mice.
| Allele Symbol | Tg(Eno2tTA)5030Nes | ||
|---|---|---|---|
| Allele Name | transgene insertion 5030, Eric Nestler | ||
| Common Name(s) | A line; NSE-tTA; Tg(Eno2-tTA)ANes; | ||
| Mutation Made By | Eric Nestler, UT Southwestern Medical Center | ||
| Strain of Origin | (SJL x C57BL/6)F1 | ||
| Site of Expression | Expresses tTA at high levels in the striatum. | ||
| Expressed Gene | tTA, tetracycline-controlled transactivator, E. coli | ||
| The tetracycline-resistance gene (TetR), arose from chemically mutated Escherichia coli genome which was screened for tetracycline dependence (Gossen and Bujard, 1992). TetR was fused at the C-terminus with the viral co-activator, virion protein 16 of the herpes simplex virus (VP-16). The tetracycline-inhibitable transcription factor is a component of a bigenic system that allows doxycycline (a tetracycline analog) regulatable expression of genes that are under the direction of the tetracycline responsive promoter (TetOp)promoter. | |||
| Promoter | Eno2, enolase 2, gamma, neuronal, rat | ||
| General Note | B6.Cg-TgN(Eno2tTA)5030Nes mice selectively express tTA at high levels in the striatum and to a lesser extent in the cerebral cortex and hippocampus. When these transgenic mice are mated to a second transgenic strain which carries a gene of interest underthe regulation of a tetracycline-responsive promoter element (TRE), expression of the target gene in the bitransgenic offspring may be induced in those tissues where tTA is expressed by the withdrawal of the tetracycline analog, doxycycline (dox). | ||
| Molecular Note | This transgene consists of a 1.8kb fragment of the rat Eno2 promoter, an SV40 intron, a poly A signal sequence, and a modified tetracycline transactivator cDNA. [MGI Ref ID J:92225] | ||
| Control | ||
|---|---|---|
| Noncarrier | ||
| 000664 C57BL/6J | ||
| Considerations for Choosing Controls | ||
Tg(tTA)
| Breeding & Husbandry | This strain originated on a B6;SJL background. Founder mice were crossed to ICR before being backcrossed to C57BL/6J (N7 7/20/00) Coat color expected from breeding:Black |
|---|---|
| Diet Information | LabDiet® 5K52/5K67 |
Strains carrying other alleles of Eno2
003833 B6.Cg-Tg(Eno2-Ighmpb2)17Cx Ighmbp2nmd-2J/Cx 006663 B6.Cg-Tg(Eno2-cre)39Jme/J 003767 B6.Cg-Tg(Eno2tTA)5021Nes/J 004360 B6;SJL-Tg(HD)63Aron/J 007860 C57BL/6J-Tg(Eno2-YFP/Cox8a)ZRwb/J 006297 FVB.Cg-Tg(Eno2-cre)39Jme/J 003753 FVB/N-Tg(Eno2CDK5R1)1Jdm/J 005938 STOCK Tg(Eno2-cre)39Jme/J View Strains carrying other alleles of Eno2 (8 strains)
Strains carrying other alleles of tTA
007004 B6.Cg-Tg(Camk2a-tTA)1Mmay/DboJ 003767 B6.Cg-Tg(Eno2tTA)5021Nes/J 005964 B6.Cg-Tg(GFAP-tTA)110Pop/J 002618 B6.Cg-Tg(MMTVtTA)1Mam/J 006361 B6.Cg-Tg(Sp7-tTA,tetO-EGFP/cre)1Amc/J 003563 B6.Cg-Tg(tTALap)5Bjd/J 002709 B6;C3-Tg(TettTALuc)1Dgs/J 003010 B6;CBA-Tg(Camk2a-tTA)1Mmay/J 008082 B6;SJL-Tg(Tagln-tTA)1Mrab Tg(tetO-Mcpt1)1Mrab/J 005625 FVB-Tg(Pcp2-tTA)3Horr/J 003170 FVB.Cg-Tg(Myh6-tTA)6Smbf/J 006209 FVB.Cg-Tg(Tal1-tTA)19Dgt/J 005942 FVB/N-Tg(Pf4-tTA/VP16)42Kra/J 004937 NOD.Cg-Tg(Ins2-tTA)1Doi/DoiJ 006999 STOCK Dbttm1Geh Tg(tTALap)5Bjd Tg(tetO-DBT)A1Geh/J 003272 STOCK Tg(tTALap)5Bjd/J 003271 STOCK Tg(tTAhCMV)3Bjd/J 003275 STOCK Tg(tetL)1Bjd/J 003274 STOCK Tg(tetNZL)2Bjd/J View Strains carrying other alleles of tTA (19 strains)
Congenic Nomenclature
Tet Expression Systems
Neurobiology Research
Tet Expression System (tTA/rtTA Expressing Strains)
Research Tools
Neurobiology Research (Tetop Tet System)
Tet Expression Systems (tTA/rtTA Expressing Strains)
Selected Reference(s)
Additional ReferencesChen J; Kelz MB; Zeng G; Sakai N; Steffen C; Shockett PE; Picciotto MR; Duman RS; Nestler EJ. 1998. Transgenic animals with inducible, targeted gene expression in brain. Mol Pharmacol 54(3):495-503. [PubMed: 9730908] [MGI Ref ID J:92225]
| Strain Name: | B6.Cg-Tg(Eno2tTA)5030Nes/J |
| Stock Number: | 003763 |
IMPORTANT NOTE: Prices are based on shipping destination. To view prices, select your shipping destination.
| Standard Supply | Repository-Cryopreserved. Must Be Recovered. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
Cryorecovery - Standard. The recovery process begins when a signed agreement form is returned to the Customer Service Department after order placement. Although results vary by strain, at least two males and two females (two pairs) will be provided, typically within 15 weeks of our receipt of the signed agreement form. If the first recovery attempt is unsuccessful or only one pair is recovered, a second recovery will be done, extending the delivery time to approximately 25 weeks. At least one member of each pair will be of known genotype and will carry the mutation if it is a mutant strain. Please note that pairs may not reflect the mating scheme utilized by The Jackson Laboratory prior to cryopreservation of the strain. Mating schemes are sometimes modified for successful cryopreservation. Price represents a repository maintenance fee, which includes the cost of recovery of the strain from the cryopreservation resource and the periodic replacement of the frozen embryos used for recovery. Cryorecovery to establish a Dedicated Supply for greater quantities of mice. |
| Licensing | See General Terms and Conditions below for Licensing and Use Restrictions |
| Control Information | View Control Information in Strain Details. |
Use of the Tet-System may require a license, see Licenses for Strains Using TET-System Technology.
For additional Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 800.422.6423 or 207.288.5845
Fax: 207.288.6150
Technical Support Email Form